Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

被引:178
作者
Pandori, MW
Fitch, NJS
Craig, HM
Richman, DD
Spina, CA
Guatelli, JC
机构
[1] UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT PATHOL,LA JOLLA,CA 92093
[3] SAN DIEGO VET AFFAIRS MED CTR,LA JOLLA,CA 92093
关键词
D O I
10.1128/JVI.70.7.4283-4290.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type 1 human immunodeficiency viruses encoding mutated nef reading frames are 10- to 30-fold less infectious than are isogenic viruses in which the nef gene is intact, This defect in infectivity causes nef-negative viruses to grow at an attenuated rate in vitro. To investigate the mechanism of Nef-mediated enhancement of viral growth rate and infectivity, a complementation analysis of nef mutant viruses was performed, To provide Nef in trans upon viral infection, a CEM derivative cell line (designated CLN) that expresses Nef under the control of the viral long terminal repeat was constructed, When nef-negative virus was grown in CLN cells, its growth rate was restored to wild-type levels. However, the output of nef-negative virus during the first 72 h after infection of CLN cells was not restored, suggesting that provision of Nef within the newly infected cell does not enhance the productivity of a nef-negative provirus. The genetically nef-negative virions produced by the CLN cells, however, were restored to wild-type levels of infectivity as measured in a syncytium formation assay in which CD4-expressing HeLa cells were targets, These trans-complemented, genetically nef-negative virions yielded wild-type levels of viral output following a single cycle of replication in primary CD4 T cells as well as in parental CEM cells, To define the determinants for producer cell modification of virions by Nef, the role of myristoylation was investigated, Virus that encodes a myristoylation-negative nef was as impaired in infectivity as was virus encoding a deleted nef gene. Because myristoylation is required for both membrane association of Nef and optimal viral infectivity, the possibility that Nef protein is included in the virion was investigated. Wild-type virions were purified by filtration and exclusion chromatography, A Western blot (immunoblot) of the eluate fractions revealed a correlation between peak Nef signal and peak Levels of p24 antigen, Although virion-associated Nef was detected in part as the 27-kDa full-length protein, the majority of immunoreactive protein was detected as a 20-kDa isoform. nef-negative virus lacked both 27- and 20-kDa immunoreactive species. Production of wild-type virions in the presence of a specific inhibitor of the human immunodeficiency virus type I protease resulted in virions which contained only 27-kDa full-length Nef protein, These data indicate that Nef is a virion protein which is processed by the viral protease into a 20-kDa isoform within the virion particle.
引用
收藏
页码:4283 / 4290
页数:8
相关论文
共 33 条
[1]   NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J].
AIKEN, C ;
KONNER, J ;
LANDAU, NR ;
LENBURG, ME ;
TRONO, D .
CELL, 1994, 76 (05) :853-864
[2]   NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J].
AIKEN, C ;
TRONO, D .
JOURNAL OF VIROLOGY, 1995, 69 (08) :5048-5056
[3]   HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION [J].
BAUR, AS ;
SAWAI, ET ;
DAZIN, P ;
FANTL, WJ ;
CHENGMAYER, C ;
PETERLIN, BM .
IMMUNITY, 1994, 1 (05) :373-384
[4]   DOWN-REGULATION OF CELL-SURFACE CD4 EXPRESSION BY SIMIAN IMMUNODEFICIENCY VIRUS NEF PREVENTS VIRAL SUPER INFECTION [J].
BENSON, RE ;
SANFRIDSON, A ;
OTTINGER, JS ;
DOYLE, C ;
CULLEN, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1561-1566
[5]   SC-52151, A NOVEL INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE [J].
BRYANT, M ;
GETMAN, D ;
SMIDT, M ;
MARR, J ;
CLARE, M ;
DILLARD, R ;
LANSKY, D ;
DECRESCENZO, G ;
HEINTZ, R ;
HOUSEMAN, K ;
REED, K ;
STOLZENBACH, J ;
TALLEY, J ;
VAZQUEZ, M ;
MUELLER, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2229-2234
[6]   DEVELOPMENT OF A SENSITIVE QUANTITATIVE FOCAL ASSAY FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTIVITY [J].
CHESEBRO, B ;
WEHRLY, K .
JOURNAL OF VIROLOGY, 1988, 62 (10) :3779-3788
[7]   THE GROWTH ADVANTAGE CONFERRED BY HIV-1 NEF IS DETERMINED AT THE LEVEL OF VIRAL-DNA FORMATION AND IS INDEPENDENT OF CD4 DOWN-REGULATION [J].
CHOWERS, MY ;
PANDORI, MW ;
SPINA, CA ;
RICHMAN, DD ;
GUATELLI, JC .
VIROLOGY, 1995, 212 (02) :451-457
[8]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[9]   THE ROLE OF NEF IN THE REPLICATION CYCLE OF THE HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES [J].
CULLEN, BR .
VIROLOGY, 1994, 205 (01) :1-6
[10]   GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS [J].
DEACON, NJ ;
TSYKIN, A ;
SOLOMON, A ;
SMITH, K ;
LUDFORDMENTING, M ;
HOOKER, DJ ;
MCPHEE, DA ;
GREENWAY, AL ;
ELLETT, A ;
CHATFIELD, C ;
LAWSON, VA ;
CROWE, S ;
MAERZ, A ;
SONZA, S ;
LEARMONT, J ;
SULLIVAN, JS ;
CUNNINGHAM, A ;
DWYER, D ;
DOWTON, D ;
MILLS, J .
SCIENCE, 1995, 270 (5238) :988-991